You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 6, June 1943 TABLE OF CONTENTS
  Archives
  •  Online Features
  Ophthalmologic Reviews
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

SULFONAMIDE COMPOUNDS IN TREATMENT OF OCULAR INFECTIONS

MAJOR PHILLIPS THYGESON

Arch Ophthal. 1943;29(6):1000-1022.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since 1937 the sulfonamide compounds have been employed with success in the treatment of an increasing number of ocular infections, and an extensive literature has already accumulated in the few years since their introduction. In the present review I have attempted to summarize the significant literature and to evaluate in the light of available laboratory studies and personal experience the sometimes conflicting clinical results reported.

SULFONAMIDE COMPOUNDS AVAILABLE FOR CLINICAL USE

Since the introduction of the original prontosil by Domagk1 in 1935, a large number of related compounds have been tested experimentally, but only a few have been found suitable for clinical use. In the United States only azosulfamide, sulfanilamide, sulfapyridine (2-[paraaminobenzenesulfonamido]-pyridine), sulfathiazole (2-[paraaminobenzenesulfonamido]-thiazole) and sulfadiazine (2-[paraaminobenzenesulfonamido]-pyrimidine) have come into general use in the treatment of ocular infections. Of these, azosulfamide and sulfapyridine have now been virtually discarded, the former because it is believed to have no action other . . . [Full Text PDF of this Article]


Author Affiliations

MEDICAL CORPS, ARMY OF THE UNITED STATES

From the Department of Ophthalmology, Columbia University College of Physicians and Surgeons, and the Institute of Ophthalmology, Presbyterian Hospital.


Footnotes

Read in part before the Pacific Coast Oto-Ophthalmological Society, Portland, Ore, May 12, 1942.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1943 American Medical Association. All Rights Reserved.